{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:27:36Z","timestamp":1782512856759,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.ejphar.2004.01.015","type":"journal-article","created":{"date-parts":[[2004,2,10]],"date-time":"2004-02-10T05:17:53Z","timestamp":1076390273000},"page":"183-197","source":"Crossref","is-referenced-by-count":86,"title":["Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist"],"prefix":"10.1016","volume":"487","author":[{"given":"Arthur A.","family":"Hancock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef L.","family":"Bennani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene N.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Esbenshade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Faghih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard B.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peer","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Knourek-Segel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrill E.","family":"Nuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Bao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty B.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2004.01.015_BIB1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","article-title":"Auto-inhibition of brain histamine release mediated by a novel class (histamine H3) of histamine receptor","volume":"30","author":"Arrang","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/nbm.704","article-title":"Non-invasive, quantitative assessment of the anatomical phenotype of corticotropin-releasing factor-overexpressing mice by MRI","volume":"14","author":"Beckman","year":"2001","journal-title":"NMR Biomed."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB3","first-page":"144","article-title":"Peripherally administered ciproxifan elevates hypothalamic histamine levels and potently reduces food intake in the Sprague Dawley rat","author":"Bjenning","year":"2000"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB4","first-page":"145","article-title":"Peripherally administered histamine H3 antagonist potently reduces snacking behavior in the obese Zucker rat","author":"Bjenning","year":"2000"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/86405","article-title":"Scientists battle obesity overload","volume":"7","author":"Bonetta","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1463-1326.2003.00249.x","article-title":"A longitudinal magnetic resonance imaging (MRI) study of differences in abdominal fat distribution between normal mice, and lean overexpressors of mitochondrial uncoupling protein-3 (UCP-3)","volume":"5","author":"Changani","year":"2003","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB48","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0163-7258(00)00105-4","article-title":"Anti-obesity drugs: a critical review of current therapies and future opportunities","volume":"89","author":"Clapham","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/abio.1999.4061","article-title":"Chimeric G-proteins allow a high-throughput signaling assay of Gi-coupled receptors","volume":"270","author":"Coward","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB9","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2337\/diabetes.50.8.1863","article-title":"Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance","volume":"50","author":"DeSouza","year":"2001","journal-title":"Diabet."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB10","series-title":"Current Protocols in Pharmacology","first-page":"1.19.1","article-title":"Characterization of histaminergic receptors","author":"Esbenshade","year":"2000"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB11","article-title":"Complex pharmacological effects of GT-2331","author":"Esbenshade","year":"2001"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/jpet.102.047183","article-title":"Two novel and selective non-imidazole histamine H3 receptor antagonists, A-304121 and A-317920: 1. In vitro pharmacological effects","volume":"305","author":"Esbenshade","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB13","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0960-894X(02)00310-4","article-title":"Structure activity relationships of non-imidazole histamine H3-receptor ligands: II. Binding preference for d-amino-acid motifs","volume":"12","author":"Faghih","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB14","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1016\/S0960-894X(02)00648-0","article-title":"Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands","volume":"12","author":"Faghih","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB15","article-title":"In vivo and ex vivo effects of ciproxifan and methylphenidate following repeated administration","author":"Fox","year":"2001"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0091-3057(02)00745-1","article-title":"Differential in vivo effects of histamine H3 receptor ligands in a new mouse dipsogenia model","volume":"72","author":"Fox","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00019616-200201000-00007","article-title":"Obesity and type 2 diabetes mellitus: a treatment challenge","volume":"12","author":"Gumbiner","year":"2002","journal-title":"Endocrinologist"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2004.01.015_BIB18","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1038\/sj.ijo.0801711","article-title":"Current pharmacological approaches to the treatment of obesity","volume":"25","author":"Hauner","year":"2001","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1124\/mol.59.3.415","article-title":"Genomics meets histamine receptors: new subtypes, new receptors","volume":"59","author":"Hough","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00401402","article-title":"Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse","volume":"13","author":"Irwin","year":"1968","journal-title":"Psychopharmacologia (Berl.)"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0006-3223(98)00044-4","article-title":"Thioperamide, a histamine H3 receptor antagonist, powerfully suppresses peptide YY-induced food intake in rats","volume":"45","author":"Itoh","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB22","article-title":"Histamine H3 receptor expression during rat development and in adult rat peripheral tissues","author":"Karlstedt","year":"2001"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2004.01.015_BIB23","first-page":"A196","article-title":"Pharmacological properties of the novel histamine H3 receptor antagonist, A-331440","volume":"44","author":"Krueger","year":"2002","journal-title":"Pharmacologist"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/jama.272.3.205","article-title":"Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991","volume":"272","author":"Kuczmarski","year":"1994","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/1522-2586(200009)12:3<488::AID-JMRI15>3.0.CO;2-5","article-title":"Imaging of water and fat fractions in high-field MRI with multiple slice chemical shift-selective inversion recovery","volume":"12","author":"Laurent","year":"2000","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s003940050040","article-title":"New approaches in the pharmacological treatment of obesity","volume":"38","author":"Leonhardt","year":"1999","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB27","first-page":"177","article-title":"Therapeutic potential of histamine H3 receptor agonists and antagonists","volume":"19","author":"Leurs","year":"1998","journal-title":"TIPS"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB28","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bjp.0703712","article-title":"Distinct pharmacology of rat and human histamine H3 receptors: role of two amino acids in the third transmembrane domain","volume":"131","author":"Ligneau","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB29","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1124\/mol.59.3.420","article-title":"Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow","volume":"59","author":"Liu","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1124\/mol.55.6.1101","article-title":"Cloning and functional expression of the human histamine H3 receptor","volume":"55","author":"Lovenberg","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB31","first-page":"771","article-title":"Cloning of rat histamine H3 receptor reveals distinct species pharmacological profiles","volume":"293","author":"Lovenberg","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003088-199835050-00003","article-title":"Inhibition and induction of cytochrome P450 and the clinical implications","volume":"35","author":"Lin","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00019053-200018040-00003","article-title":"Socioeconomic issues affecting the treatment of obesity in the new millennium","volume":"18","author":"Martin","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0031-9384(99)00123-7","article-title":"Involvement of the histaminergic system in leptin-induced suppression of food intake","volume":"67","author":"Morimoto","year":"1999","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0166-4328(01)00225-X","article-title":"Brain histamine and feeding behavior","volume":"124","author":"Morimoto","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35048583","article-title":"High constitutive activity of native histamine H3 receptors regulates histamine neurons in brain","volume":"408","author":"Morisset","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB37","doi-asserted-by":"crossref","first-page":"36781","DOI":"10.1074\/jbc.M006480200","article-title":"Molecular cloning and characterization of novel type of histamine receptor preferentially expressed in leukocytes","volume":"275","author":"Oda","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-2999(90)90674-U","article-title":"Is monoamine turnover in the brain regulated by histamine H3 receptors?","volume":"184","author":"Oishi","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB39","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0031-9384(92)90132-L","article-title":"FMS-induced decrease in central histamine levels produces increased feeding and body weight in rats","volume":"51","author":"Orthen-Gambill","year":"1992","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB40","first-page":"112","article-title":"Morphological identification of brown adipose tissue by magnetic resonance imaging in the rat","volume":"9","author":"Osculati","year":"1989","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB41","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1152\/jappl.1991.70.5.2164","article-title":"Adipose tissue volume measured by magnetic resonance imaging and computerized tomography in rats","volume":"70","author":"Ross","year":"1991","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0899-9007(97)91277-6","article-title":"Hypothalamic neuronal histamine-implications of its homeostatic control of energy metabolism","volume":"13","author":"Sakata","year":"1997","journal-title":"Nutrition"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB43","first-page":"457","article-title":"Plasma concentration and brain penetration of the histamine H3-receptor antagonist thioperamide in rats","volume":"52","author":"Silva","year":"1997","journal-title":"Farmaco"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB44","first-page":"1160","article-title":"Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligands","volume":"289","author":"Tedford","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB45","first-page":"908","article-title":"Constitutive activity of histamine H3 receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by histamine H3 antagonists","volume":"299","author":"Wieland","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.01.015_BIB46","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0028-3908(03)00056-X","article-title":"Molecular modeling and pharmacological analysis of species-related histamine H3 receptor heterogeneity","volume":"44","author":"Yao","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2004.01.015_BIB47","article-title":"Effects of a novel histamine H3 receptor antagonist, GT-2394, on food intake and weight gain in Sprague\u2013Dawley rats","author":"Yates","year":"2000"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904000767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904000767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T23:53:54Z","timestamp":1550188434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299904000767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":48,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0014299904000767"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2004.01.015","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}